Ying Shang (Y Shang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Topics

Insulin Resistance

Community Dwelling

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Ying Shang, Emilie Toresson Grip, Angelo Modica, Helena Skröder, Oskar Ström, Fady Ntanios, Soffia Gudbjörnsdottir, Hannes Hagström
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. Diabetes care 47 (6) (2024)
Ying Shang, Emilie Toresson Grip, Angelo Modica, Helena Skröder, Oskar Ström, Fady Ntanios, Soffia Gudbjörnsdottir, Hannes Hagström
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. Diabetes care 47 (6) (2024)
Ying Shang, Camilla Akbari, Maja Dodd, Patrik Nasr, Johan Vessby, Fredrik Rorsman, Stergios Kechagias, Per Stål, Mattias Ekstedt, Hannes Hagström
Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD. Gut (2024)
Ying Shang, Emilie Toresson Grip, Angelo Modica, Helena Skröder, Oskar Ström, Fady Ntanios, Soffia Gudbjörnsdottir, Hannes Hagström
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. Diabetes care 47 (6) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Hanne Åström, Ying Shang, Hannes Hagström, Axel Wester
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression. Liver international : official journal of the International Association for the Study of the Liver (2024)
Xiao-Dong Zhou, Seung-Up Kim, Terry Cheuk Fung Yip, Salvatore Petta, Atsushi Nakajima, Emmanuel Tsochatzis, Jérôme Boursier, Elisabetta Bugianesi, Hannes Hagström, Wah-Kheong Chan, Manuel Romero, Jose Luis Calleja, Victor de Lédinghen, Laurent Castéra, Arun J Sanyal, George Boon-Bee Goh, Philip Noel Newsome, Jiangao Fan, Michelle Lai, Céline Fournier-Poizat, Hye-Won Lee, Grace Lai-Hung Wong, Angelo Armandi, Ying Shang, Grazia Pennisi, Elba Llop, Masato Yoneda, Marc de Saint-Loup, Clémence M Canivet, Carmen Lara-Romero, Rocio Gallego-Duràn, Amon Asgharpour, Kevin Kim-Jun Teh, Sara Mahgoub, Mandy Sau-Wai Chan, Huapeng Lin, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Ming-Hua Zheng, null null
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. Gut (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Patrik Nasr, Ying Shang, Axel Wester, Rickard Strandberg, Linnea Widman, Jeffrey Victor Lazarus, Hannes Hagström
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease. Liver international : official journal of the International Association for the Study of the Liver (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Ying Shang, Emilie Toresson Grip, Angelo Modica, Helena Skröder, Oskar Ström, Fady Ntanios, Soffia Gudbjörnsdottir, Hannes Hagström
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. Diabetes care (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut (2024)
Ying Shang, Linnea Widman, Fahim Ebrahimi, Jonas F Ludvigsson, Hannes Hagström, Axel Wester
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Ying Shang, Qing Shen, Elliot B Tapper, Axel Wester, Hannes Hagström
Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study. Hepatology communications 7 (11) (2023)
Axel Wester, Ying Shang, Per Stål, Hannes Hagström
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study. Hepatology communications 7 (10) (2023)
Ying Shang, Patrik Nasr, Linnea Widman, Hannes Hagström
Risk of cardiovascular disease and loss in life expectancy in NAFLD. Hepatology (Baltimore, Md.) 76 (5) (2022)
Hannes Hagström, Ying Shang
Less is more? Screening for steatosis in older populations. Hepatology (Baltimore, Md.) (2022)
Ying Shang, Linnea Widman, Hannes Hagström
Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study. Neurology 99 (6) (2022)
Ying Shang, Laura Fratiglioni, Davide Liborio Vetrano, Abigail Dove, Anna-Karin Welmer, Wei-Li Xu
Not Only Diabetes but Also Prediabetes Leads to Functional Decline and Disability in Older Adults. Diabetes care 44 (3) (2021)
Ying Shang, Wei-Li Xu
Clarifications on blood pressure measurements and the validity of the conclusions. Journal of internal medicine 286 (6) (2019)
Ying Shang, A Marseglia, L Fratiglioni, A-K Welmer, R Wang, H-X Wang, Wei-Li Xu
Natural history of prediabetes in older adults from a population-based longitudinal study. Journal of internal medicine 286 (3) (2019)